Travel & financial grants

Bausch

The WD Rx Access program, sponsored by Bausch, offers patient assistance for Cuprimine and Syprine medications. It is open for eligible patients, including an enhanced program for Medicaid-only patients beginning October 1st. Patients need to re-enroll annually for assistance.

Wilson Disease Association

The Wilson Disease Association Patient Assistance Program page primarily outlines various initiatives focused on providing or facilitating access to prescription medications for Wilson disease patients. It details specific drug assistance programs from pharmaceutical companies for U.S. patients and an international medication assistance program. This page does not offer any grants specifically for travel assistance.

Karyopharm Therapeutics Inc.

The XPOVIO Copay Program, offered by Karyopharm Therapeutics Inc. through its KaryForward patient support program, provides financial assistance to eligible patients for their XPOVIO prescriptions. Qualified individuals may pay as little as $5 per prescription or receive the medication at no cost. While primarily covering prescription costs, the KaryForward program also offers referrals for third-party transportation assistance and other patient resources.

Blueprint Medicines Corporation

This page details financial assistance programs offered by YourBlueprint, primarily focusing on co-pay assistance for prescriptions (up to $25,000 annually) and a patient assistance program providing free medication. It does not mention or describe any specific patient travel assistance grant or coverage for travel-related expenses.

Accessia Health

The Accessia Health GIST program provides financial assistance for patients with Gastrointestinal Stromal Tumors, covering medication copayments, premiums, ancillary services, infusion, nursing, and travel. Eligible applicants must be residents of the US or Puerto Rico, have public insurance (Medicare/Medicaid), and demonstrate financial need, requiring income documentation.

Accessia Health

The Accessia Health program offers financial assistance for patients with Gastrointestinal Stromal Tumors (GIST) who have public insurance (Medicare/Medicaid) and demonstrate financial need. This grant covers medication copayments, premiums, ancillary services, infusion, nursing services, and travel, with an annual maximum benefit of $4500. Applicants must reside in the US or Puerto Rico and provide income documentation.

Accessia Health

This Accessia Health program provides up to $4500 annually in financial assistance for patients with Gastrointestinal Stromal Tumors (GIST) who have public insurance. Support may cover medication copayments, premiums, ancillary services, and travel expenses. Eligibility is needs-based, requires US or Puerto Rico residency, and applicants must provide income, diagnosis, and insurance documentation.

Accessia Health

The Accessia Health Myelodysplastic Syndromes grant offers financial support for patients with myelodysplastic syndromes who reside in the US or Puerto Rico. Benefits may include copayment, premium, ancillary services, infusion and nursing services, or travel. The program is needs-based, requires supporting income documentation, and is currently accepting applications for a waitlist.

Accessia Health

This Accessia Health program provides up to $3800 annually for US and Puerto Rico residents with Primary Immune Deficiency and public insurance (Medicare/Medicaid). It offers financial assistance for copayments, premiums, ancillary services, infusion/nursing, and travel. Applicants must demonstrate financial need with income documentation; however, the program is currently on a waitlist and not funded, meaning applications are not actively being processed for awards.

Accessia Health

The Accessia Health GIST program provides needs-based financial assistance for patients with Gastrointestinal Stromal Tumors, covering copayment, premium, ancillary services, infusion, nursing, and travel. Eligible applicants must reside in the US or Puerto Rico, have Medicare or Medicaid insurance, and provide income documentation. The program offers a $4500 annual maximum benefit, and applications are currently on a waitlist.

Accessia Health

This Accessia Health program offers an annual maximum benefit of $5500 to assist with copayments, premiums, ancillary services, infusion and nursing services, and travel. It is available to US and Puerto Rico residents with Medicare/Medicaid who require Aldurazyme and meet financial and medical eligibility, including providing income documentation.

The Assistance Fund

The Acromegaly Financial Assistance Program, sponsored by The Assistance Fund, provides financial grants to help patients with out-of-pocket medical costs, including prescription drug copays, health insurance premiums, therapy administration, and travel expenses for treatment. To qualify, patients must be U.S. citizens or permanent residents diagnosed with Acromegaly, prescribed an FDA-approved treatment with coverage, and meet financial eligibility based on household income and size. The program is currently operating on a waitlist basis.

The Assistance Fund

The Assistance Fund: Infantile Spasms: Waitlist program offers financial assistance for copays, coinsurance, deductibles, health insurance premiums, and other medical expenses related to FDA-approved and potentially off-label treatments for infantile spasms. It supports eligible patients under the age of 2 who are US or Puerto Rico residents, are commercially insured or have Medicare/Medicaid, and whose applicants must be 18 years or older. Eligibility is needs-based.

The Assistance Fund

The Assistance Fund: Small Cell Lung Cancer (SCLC) program offers financial support for eligible SCLC patients residing in the US and Puerto Rico, who are commercially insured or covered by Medicare/Medicaid and demonstrate financial need. It covers copays, coinsurance, deductibles, health insurance premiums, and incidental medical expenses for FDA-approved and potentially off-label treatments. The program is currently operating on a waitlist.

Patient Access Network (PAN) Foundation

The PAN: Non-Hodgkin's Lymphoma (Medicare): Waitlist program offers financial assistance for medication costs to eligible US and Puerto Rico residents with Medicare coverage for Non-Hodgkin's Lymphoma. It provides an annual maximum benefit of $3600 and is needs-based, requiring patients to meet specific income criteria to qualify for funding for drugs like Rituxan, Revlimid, and Imbruvica.

QuickRx

This QuickRx grant provides copay assistance for Pomalyst (pomalidomide) medication to patients with multiple myeloma. It helps commercially insured, Medicare, Medicaid, and uninsured patients reduce out-of-pocket costs to $0 by coordinating manufacturer copay cards, patient assistance programs, and foundation grants. The assistance also includes insurance benefit verification, prior authorization support, and nationwide home delivery.

The Assistance Fund

The Assistance Fund - Juvenile Arthritis Waitlist offers needs-based financial assistance for patients under 17 with juvenile arthritis who reside in the US or Puerto Rico and are commercially insured, or have Medicare/Medicaid. The program covers drug costs (copays, coinsurance, deductibles) for FDA-approved and potentially off-label treatments, as well as other out-of-pocket medical expenses like health insurance premiums and incidental costs. Applicants must be 18 years or older.

The Assistance Fund

The Assistance Fund's Hemophilia Financial Assistance Program helps patients with out-of-pocket costs such as prescription drugs, health insurance premiums, therapy administration, ground travel to treatment centers, and genetic testing. To qualify, patients must be a U.S. citizen or permanent resident, diagnosed with Hemophilia, prescribed an FDA-approved treatment, have prescription coverage, and meet financial eligibility criteria based on household income and size. The program is currently accepting waitlist applications.

The Assistance Fund

The Assistance Fund: Lupus program provides financial support for U.S. citizens or permanent residents diagnosed with lupus who are prescribed specific FDA-approved treatments. It helps cover copays, coinsurance, deductibles, health insurance premiums, and incidental medical expenses. Eligibility is determined by household income and size, and applicants must have commercial insurance, Medicare, or Medicaid.

The Assistance Fund

The Assistance Fund: Non-Small Cell Lung Cancer (NSCLC) program provides needs-based financial assistance for copays, coinsurance, and deductibles for FDA-approved NSCLC treatments. It is available to commercially insured, Medicare/Medicaid, underinsured, and uninsured residents of the US and Puerto Rico. While the main program is currently not funded, a waitlist option for future assistance is available.

The Assistance Fund

The Assistance Fund: Thyroid Cancer: Waitlist program provides financial support for FDA-approved thyroid cancer treatments, covering copays, coinsurance, deductibles, health insurance premiums, and incidental medical expenses. It is available to commercially insured, Medicare, or Medicaid patients residing in the US and Puerto Rico who demonstrate financial need.

AbbVie Patient Assistance Foundation

The AbbVie Patient Assistance Foundation provides various AbbVie prescription medications, such as Androgel, Creon, Humira, Lupron Depot, and others, at no cost. It is designed for patients experiencing financial difficulties who may or may not have prescription medication benefits through private insurance or government programs.

Accessia Health

The Accessia Health Kidney Stones Financial Assistance program offers financial support for US and Puerto Rico residents with public insurance (Medicare/Medicaid) needing medications for kidney stones, such as Cystadane. The needs-based program covers copayments, premiums, ancillary services, infusion and nursing services, and travel, with an annual maximum benefit of $5000.